Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peri-operative Tamsulosin for Voiding After Urogynecology Surgery
NCT06843538Phase 3Recruiting
- Sponsor
- TriHealth
- Start
- Feb 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tamsulosin in postoperative urinary retention (POUR), sponsored by TriHealth. Started Feb 2025; status: recruiting.
02
Drugs
tamsulosin
03
Conditions
postoperative urinary retention (POUR)
Beyond the preview
Go deeper on NCT06843538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06843538.